TVTX
Travere Therapeutics Inc
$44.74
+2.87% (+$1.25)
Volume
1.32M
52W High
$48.61
52W Low
$13.88
Market Cap
$4.14B
Next Earnings Report
Last Reported
May 4, 2026 Beat
Actual: $0.05
vs. Consensus: -$0.10
Price Chart
EPS History: Consensus vs Actual
Last 12 quartersPrice Movement Around Earnings
Q1 2026
May 4, 2026
1-Day:
-0.24%
Q1 2026
Apr 30, 2026
1-Day:
+4.75%
5-Day:
+6.36%
Q4 2025
Feb 20, 2026
5-Day:
-3.46%
Q4 2025
Feb 19, 2026
1-Day:
+3.72%
5-Day:
+5.39%
Revenue & Financial Performance
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'25 | $129.7M | +73.4% | 84.1% | -25.0% | -$22.0M |
| Q3'25 | $164.9M | +162.1% | 99.0% | 15.1% | $25.7M |
| Q2'25 | $114.4M | +111.5% | 98.7% | -11.1% | -$12.8M |
| Q1'25 | $81.7M | +97.5% | 94.3% | -52.2% | -$41.2M |
| Q4'24 | $74.8M | +66.0% | 96.6% | -81.2% | -$60.3M |
| Q3'24 | $62.9M | +69.6% | 97.4% | -89.3% | -$54.8M |
| Q2'24 | $54.1M | +68.1% | 77.1% | -123.9% | -$70.4M |
| Q1'24 | $41.4M | -27.4% | 96.4% | -336.5% | -$136.1M |
Company Information
Symbol
TVTX
Company
Travere Therapeutics Inc
Market Cap
$4.14B